{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:02:09Z","timestamp":1779217329198,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,11]]},"DOI":"10.7759\/cureus.89784","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T10:24:55Z","timestamp":1754907895000},"source":"Crossref","is-referenced-by-count":1,"title":["Angiotensin-Converting Enzyme Inhibitor (ACEI)-Induced Angioedema After Re-exposure to Lisinopril: A Case Report and Clinical Review"],"prefix":"10.7759","author":[{"given":"Leila C","family":"Tou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob D","family":"DeMott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0859-x","article-title":"ACE inhibitor-induced angioedema: a review","volume":"20","author":"Kostis WJ","year":"2018","unstructured":"Kostis WJ, Shetty M, Chowdhury YS, Kostis JB. ACE inhibitor-induced angioedema: a review. Curr Hypertens Rep. 2018, 20:55. 10.1007\/s11906-018-0859-x","journal-title":"Curr Hypertens Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106081","article-title":"ACE inhibitor-mediated angioedema","volume":"78","author":"Montinaro V","year":"2020","unstructured":"Montinaro V, Cicardi M. ACE inhibitor-mediated angioedema. Int Immunopharmacol. 2020, 78:106081. 10.1016\/j.intimp.2019.106081","journal-title":"Int Immunopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148373","article-title":"Adverse effects of angiotensin-converting enzyme inhibitors in humans: a systematic review and meta-analysis of 378 randomized controlled trials","volume":"19","author":"Na Takuathung M","year":"2022","unstructured":"Na Takuathung M, Sakuludomkan W, Khatsri R, et al.. Adverse effects of angiotensin-converting enzyme inhibitors in humans: a systematic review and meta-analysis of 378 randomized controlled trials. Int J Environ Res Public Health. 2022, 19:10.3390\/ijerph19148373","journal-title":"Int J Environ Res Public Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study","volume":"78","author":"Chen R","year":"2021","unstructured":"Chen R, Suchard MA, Krumholz HM, et al.. Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension. 2021, 78:591-603. 10.1161\/HYPERTENSIONAHA.120.16667","journal-title":"Hypertension"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40320","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: a case report with a review of management options","volume":"15","author":"Ameer MA","year":"2023","unstructured":"Ameer MA, Mushtaq J, Chaudhry H, Patel N, Khan SI. Angiotensin-converting enzyme inhibitor-induced angioedema: a case report with a review of management options. Cureus. 2023, 15:e40320. 10.7759\/cureus.40320","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1676391","article-title":"A forgotten cause of allergy at ER that is still difficult to diagnose and treat at poor resource setting: angioedema after using angiotensin converting enzyme inhibitors for 4 years","volume":"2019","author":"Nishad AA","year":"2019","unstructured":"Nishad AA, Arulmoly K, Priyankara SA, Abeysundara PK. A forgotten cause of allergy at ER that is still difficult to diagnose and treat at poor resource setting: angioedema after using angiotensin converting enzyme inhibitors for 4 years. Case Reports Immunol. 2019, 2019:1676391. 10.1155\/2019\/1676391","journal-title":"Case Reports Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2023.100809","article-title":"Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers","volume":"16","author":"Douillard M","year":"2023","unstructured":"Douillard M, Deheb Z, Bozon A, et al.. Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. World Allergy Organ J. 2023, 16:100809. 10.1016\/j.waojou.2023.100809","journal-title":"World Allergy Organ J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12245-017-0141-z","article-title":"Angioedema in the emergency department: a practical guide to differential diagnosis and management","volume":"10","author":"Bernstein JA","year":"2017","unstructured":"Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017, 10:15. 10.1186\/s12245-017-0141-z","journal-title":"Int J Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2024.02.006","article-title":"Tranexamic acid for angiotensin converting enzyme inhibitor induced angioedema: a retrospective multicenter study","volume":"79","author":"Lindauer KE","year":"2024","unstructured":"Lindauer KE, Lo BM, Weingart GS, Karpov MV, Gartman GH, Neubauer LE, Kaplan MC. Tranexamic acid for angiotensin converting enzyme inhibitor induced angioedema: a retrospective multicenter study. Am J Emerg Med. 2024, 79:33-7. 10.1016\/j.ajem.2024.02.006","journal-title":"Am J Emerg Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2003.09.014","article-title":"Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial","volume":"17","author":"Kostis JB","year":"2004","unstructured":"Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens. 2004, 17:103-11. 10.1016\/j.amjhyper.2003.09.014","journal-title":"Am J Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf S","year":"2008","unstructured":"Yusuf S, Teo KK, Pogue J, et al.. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008, 358:1547-59. 10.1056\/NEJMoa0801317","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401017-angiotensin-converting-enzyme-inhibitor-acei-induced-angioedema-after-re-exposure-to-lisinopril-a-case-report-and-clinical-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T10:24:56Z","timestamp":1754907896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401017-angiotensin-converting-enzyme-inhibitor-acei-induced-angioedema-after-re-exposure-to-lisinopril-a-case-report-and-clinical-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.89784","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}